9-36215154-G-C

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_005476.7(GNE):​c.*2211C>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0128 in 151,662 control chromosomes in the GnomAD database, including 35 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.013 ( 35 hom., cov: 32)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

GNE
NM_005476.7 3_prime_UTR

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.634
Variant links:
Genes affected
GNE (HGNC:23657): (glucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase) The protein encoded by this gene is a bifunctional enzyme that initiates and regulates the biosynthesis of N-acetylneuraminic acid (NeuAc), a precursor of sialic acids. It is a rate-limiting enzyme in the sialic acid biosynthetic pathway. Sialic acid modification of cell surface molecules is crucial for their function in many biologic processes, including cell adhesion and signal transduction. Differential sialylation of cell surface molecules is also implicated in the tumorigenicity and metastatic behavior of malignant cells. Mutations in this gene are associated with sialuria, autosomal recessive inclusion body myopathy, and Nonaka myopathy. Alternative splicing of this gene results in transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]
CLTA (HGNC:2090): (clathrin light chain A) Clathrin is a large, soluble protein composed of heavy and light chains. It functions as the main structural component of the lattice-type cytoplasmic face of coated pits and vesicles which entrap specific macromolecules during receptor-mediated endocytosis. This gene encodes one of two clathrin light chain proteins which are believed to function as regulatory elements. Alternative splicing results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 8 and 12. [provided by RefSeq, May 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 9-36215154-G-C is Benign according to our data. Variant chr9-36215154-G-C is described in ClinVar as [Likely_benign]. Clinvar id is 366806.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0128 (1936/151662) while in subpopulation NFE AF= 0.0176 (1197/67938). AF 95% confidence interval is 0.0168. There are 35 homozygotes in gnomad4. There are 983 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 35 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
GNENM_001128227.3 linkuse as main transcriptc.*2211C>G 3_prime_UTR_variant 12/12 ENST00000396594.8 NP_001121699.1 Q9Y223-2
GNENM_005476.7 linkuse as main transcriptc.*2211C>G 3_prime_UTR_variant 12/12 ENST00000642385.2 NP_005467.1 Q9Y223-1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
GNEENST00000396594 linkuse as main transcriptc.*2211C>G 3_prime_UTR_variant 12/121 NM_001128227.3 ENSP00000379839.3 Q9Y223-2
GNEENST00000642385 linkuse as main transcriptc.*2211C>G 3_prime_UTR_variant 12/12 NM_005476.7 ENSP00000494141.2 Q9Y223-1
CLTAENST00000464497.5 linkuse as main transcriptn.485+10975G>C intron_variant 5 ENSP00000419158.1 F8WF69

Frequencies

GnomAD3 genomes
AF:
0.0128
AC:
1936
AN:
151544
Hom.:
35
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00283
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00218
Gnomad ASJ
AF:
0.0409
Gnomad EAS
AF:
0.000195
Gnomad SAS
AF:
0.00168
Gnomad FIN
AF:
0.0395
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.0176
Gnomad OTH
AF:
0.00967
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
0.00
AC:
0
AN:
40
Hom.:
0
Cov.:
0
AF XY:
0.00
AC XY:
0
AN XY:
26
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.0128
AC:
1936
AN:
151662
Hom.:
35
Cov.:
32
AF XY:
0.0133
AC XY:
983
AN XY:
74080
show subpopulations
Gnomad4 AFR
AF:
0.00283
Gnomad4 AMR
AF:
0.00218
Gnomad4 ASJ
AF:
0.0409
Gnomad4 EAS
AF:
0.000196
Gnomad4 SAS
AF:
0.00168
Gnomad4 FIN
AF:
0.0395
Gnomad4 NFE
AF:
0.0176
Gnomad4 OTH
AF:
0.00957
Alfa
AF:
0.00838
Hom.:
5
Bravo
AF:
0.00957

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Sialuria Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
GNE myopathy Benign:1
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 14, 2016- -
not provided Benign:1
Likely benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Inclusion Body Myopathy, Recessive Benign:1
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 14, 2016- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
3.8
DANN
Benign
0.86

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs150978860; hg19: chr9-36215151; API